EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Rhoen Klinikum AG's enterprise value is €661 Mil.
Rhoen Klinikum AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €117 Mil. Therefore, Rhoen Klinikum AG's EV-to-EBITDA for today is 5.65.
The historical rank and industry rank for Rhoen Klinikum AG's EV-to-EBITDA or its related term are showing as below:
XTER:RHK'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -66.62 Med: 8.44 Max: 19.48
Current: 5.64
During the past 13 years, the highest EV-to-EBITDA of Rhoen Klinikum AG was 19.48. The lowest was -66.62. And the median was 8.44.
XTER:RHK's EV-to-EBITDA is ranked better than 84.42% of 462
companies
in the Healthcare Providers & Services industry
Industry Median: 12.98
vs XTER:RHK: 5.64
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Rhoen Klinikum AG EV-to-EBITDA Historical Data
The historical data trend for Rhoen Klinikum AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Rhoen Klinikum AG's EV-to-EBITDA
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's EV-to-EBITDA falls into.
Rhoen Klinikum AG's current Enterprise Value is €661 Mil.
Rhoen Klinikum AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €117 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhoen Klinikum AG (XTER:RHK) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Rhoen Klinikum AG's PE Ratio for today is calculated as:
Rhoen Klinikum AG's share price for today is €12.90.
Rhoen Klinikum AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.580.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Rhoen Klinikum AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:RHK has been successfully added to your 